Lentiviral Vector Design for Multiple shRNA Expression and Durable HIV-1 Inhibition
暂无分享,去创建一个
Ben Berkhout | B. Berkhout | M. Centlivre | Mireille Centlivre | Olivier ter Brake | Karen 't Hooft | Ying Poi Liu | Karin Jasmijn von Eije | Ying Liu | O. Brake | Karin Jasmijn von Eije | O. T. Brake
[1] B. Berkhout,et al. Lentiviral vectors that carry anti‐HIV shRNAs: problems and solutions , 2007, The journal of gene medicine.
[2] A. Jetzt,et al. Human Immunodeficiency Virus Type 1 Recombination: Rate, Fidelity, and Putative Hot Spots , 2002, Journal of Virology.
[3] S. Barik,et al. Inhibition of respiratory viruses by nasally administered siRNA , 2005, Nature Medicine.
[4] Joshua N. Leonard,et al. Computational Design of Antiviral RNA Interference Strategies That Resist Human Immunodeficiency Virus Escape , 2005, Journal of Virology.
[5] B. Ramratnam,et al. Promoter choice affects the potency of HIV-1 specific RNA interference. , 2003, Nucleic acids research.
[6] B. Berkhout. RNA interference as an antiviral approach: targeting HIV-1. , 2004, Current opinion in molecular therapeutics.
[7] Ben Berkhout,et al. HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome , 2005, Nucleic acids research.
[8] B. Berkhout,et al. Design of extended short hairpin RNAs for HIV-1 inhibition , 2007, Nucleic Acids Research.
[9] B. Berkhout,et al. In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[10] R. Bernards,et al. A System for Stable Expression of Short Interfering RNAs in Mammalian Cells , 2002, Science.
[11] B. Berkhout,et al. A novel approach for inhibition of HIV-1 by RNA interference: counteracting viral escape with a second generation of siRNAs , 2005, Journal of RNAi and gene silencing : an international journal of RNA and gene targeting research.
[12] B. Palmer,et al. Safety and Efficacy of a Lentiviral Vector Containing Three Anti-HIV Genes-CCR5 Ribozyme, Tat-rev siRNA, and TAR Decoy-in SCID-hu Mouse-Derived T Cells. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.
[13] G. Nolan,et al. Gene therapy progress and prospects: Novel gene therapy approaches for AIDS , 2005, Gene Therapy.
[14] Anne Gatignol,et al. Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC , 2007, Nucleic acids research.
[15] B. Scholte,et al. Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[16] Wulin Teo,et al. An Essential Role for LEDGF/p75 in HIV Integration , 2006, Science.
[17] Ben Berkhout,et al. Silencing of HIV-1 with RNA interference: a multiple shRNA approach. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[18] A. Kingsman,et al. A Rev-Independent Human Immunodeficiency Virus Type 1 (HIV-1)-Based Vector That Exploits a Codon-Optimized HIV-1gag-pol Gene , 2000, Journal of virology.
[19] W. An,et al. Frequency of direct repeat deletion in a human immunodeficiency virus type 1 vector during reverse transcription in human cells. , 2001, Virology.
[20] T. Morio,et al. Hematopoietic stem cell–engrafted NOD/SCID/IL2Rγnull mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses , 2007 .
[21] Milton C Weinstein,et al. The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United States , 2006, Medical care.
[22] B. Blom,et al. Monitoring the effect of gene silencing by RNA interference in human CD34+ cells injected into newborn RAG2-/- gammac-/- mice: functional inactivation of p53 in developing T cells. , 2004, Blood.
[23] S. Deeks. Antiretroviral treatment of HIV infected adults , 2006, BMJ : British Medical Journal.
[24] J. Seppen,et al. Lentiviral vectors for efficient transduction of isolated primary quiescent hepatocytes. , 2002, Journal of hepatology.
[25] B. Berkhout,et al. The virion-associated incoming HIV-1 RNA genome is not targeted by RNA interference , 2006, Retrovirology.
[26] B. Palmer,et al. HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-γc-/- (RAG-hu) mouse model , 2006, Retrovirology.
[27] B. Sandrock,et al. RNA interference by small hairpin RNAs synthesised under control of the human 7S K RNA promoter , 2004, Biological chemistry.
[28] I. Bozzoni,et al. A new vector, based on the PolII promoter of the U1 snRNA gene, for the expression of siRNAs in mammalian cells. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.
[29] J. Inoue,et al. Lentivirus vectors expressing short hairpin RNAs against the U3-overlapping region of HIV nef inhibit HIV replication and infectivity in primary macrophages. , 2006, Blood.
[30] A. Jetzt,et al. High Rate of Recombination throughout the Human Immunodeficiency Virus Type 1 Genome , 2000, Journal of Virology.
[31] B. Berkhout,et al. Inhibition of human immunodeficiency virus type 1 by RNA interference using long-hairpin RNA , 2006, Gene Therapy.
[32] B. Ramratnam,et al. Human Immunodeficiency Virus Type 1 Escape from RNA Interference , 2003, Journal of Virology.
[33] L. Greensmith,et al. Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model , 2005, Nature Medicine.
[34] B. Berkhout,et al. The interplay between virus infection and the cellular RNA interference machinery , 2006, FEBS Letters.
[35] Ben Berkhout,et al. Human Immunodeficiency Virus Type 1 Escapes from RNA Interference-Mediated Inhibition , 2004, Journal of Virology.
[36] T. Morio,et al. Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses. , 2007, Blood.
[37] M. Kay,et al. Combinatorial RNAi: A Winning Strategy for the Race Against Evolving Targets? , 2007, Molecular Therapy.
[38] Stacy L DeRuiter,et al. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[39] J. Rossi,et al. Novel Pol II Fusion Promoter Directs Human Immunodeficiency Virus Type 1-Inducible Coexpression of a Short Hairpin RNA and Protein , 2006, Journal of Virology.
[40] B. Harder,et al. Lentivirus vectors encoding both central polypurine tract and posttranscriptional regulatory element provide enhanced transduction and transgene expression. , 2001, Human gene therapy.
[41] R. Surabhi,et al. RNA Interference Directed against Viral and Cellular Targets Inhibits Human Immunodeficiency Virus Type 1 Replication , 2002, Journal of Virology.
[42] H. Paulson,et al. RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[43] B. Nuttin,et al. Lentiviral vector-mediated delivery of short hairpin RNA results in persistent knockdown of gene expression in mouse brain. , 2003, Human gene therapy.
[44] H. Spits,et al. Experimental Models to Study Development and Function of the Human Immune System In Vivo , 2006, The Journal of Immunology.
[45] John J Rossi,et al. Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.
[46] J. Rossi,et al. Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.
[47] M. Emerman,et al. Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI. , 1991, Virology.
[48] John R. Mascola,et al. Gene transfer in humans using a conditionally replicating lentiviral vector , 2006, Proceedings of the National Academy of Sciences.
[49] J. Rossi,et al. Current status of gene therapy strategies to treat HIV/AIDS. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.
[50] M. Kumar,et al. Systematic determination of the packaging limit of lentiviral vectors. , 2001, Human gene therapy.
[51] Yingchun Lu,et al. Poly(U) and polyadenylation termination signals are interchangeable for terminating the expression of shRNA from a pol II promoter. , 2004, Biochemical and biophysical research communications.
[52] R. Akkina,et al. HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector , 2005, AIDS research and therapy.